Description

PURETRIG 5000 IU HP

Indications

PURETRIG 5000 IU HP is a high-potency formulation of vitamin D3 (cholecalciferol) indicated for the treatment and prevention of vitamin D deficiency and insufficiency in adults and children. It is particularly beneficial for individuals at risk of deficiency due to limited sun exposure, malabsorption syndromes, or specific dietary restrictions. This product is also indicated for the management of conditions associated with impaired calcium metabolism, such as osteoporosis, osteomalacia, and certain types of rickets.

Mechanism of Action

Vitamin D3 is a fat-soluble vitamin that plays a crucial role in calcium and phosphate metabolism. Once ingested, cholecalciferol is converted in the liver to 25-hydroxyvitamin D (calcidiol) and subsequently in the kidneys to its active form, 1,25-dihydroxyvitamin D (calcitriol). Calcitriol enhances intestinal absorption of calcium and phosphate, promotes bone mineralization, and regulates parathyroid hormone levels, thereby maintaining bone health and overall mineral balance in the body.

Pharmacological Properties

PURETRIG 5000 IU HP contains a high concentration of vitamin D3, which is known for its superior bioavailability compared to other forms of vitamin D. The pharmacokinetics of vitamin D3 involve its absorption in the intestines, distribution in body tissues, and metabolism in the liver and kidneys. The half-life of vitamin D3 is approximately 15 days, and its effects can last for several weeks post-administration. This formulation is designed to provide a sustained release of vitamin D, ensuring optimal levels are maintained in the body.

Contraindications

PURETRIG 5000 IU HP is contraindicated in individuals with a known hypersensitivity to vitamin D or any of the excipients in the formulation. It should also be avoided in patients with hypercalcemia, hyperphosphatemia, or vitamin D toxicity, as excessive levels can lead to serious health complications. Additionally, individuals with certain granulomatous diseases, such as sarcoidosis, may have an increased sensitivity to vitamin D and should use this product with caution.

Side Effects

While PURETRIG 5000 IU HP is generally well-tolerated, some individuals may experience side effects. Common side effects include gastrointestinal disturbances such as nausea, vomiting, and constipation. Rarely, hypercalcemia may occur, leading to symptoms such as weakness, confusion, and kidney stones. Long-term excessive intake of vitamin D can result in more severe complications, including calcification of soft tissues and renal impairment. It is essential to monitor serum calcium and vitamin D levels during prolonged use.

Dosage and Administration

The recommended dosage of PURETRIG 5000 IU HP varies based on the individual’s age, health status, and specific needs. For adults, the standard dose for the treatment of vitamin D deficiency is typically 5000 IU once daily or as directed by a healthcare professional. For children, the dosage should be adjusted according to their age and weight, generally not exceeding 2000 IU per day unless prescribed by a physician. It is advisable to take the supplement with a meal to enhance absorption, as vitamin D is fat-soluble.

Interactions

PURETRIG 5000 IU HP may interact with certain medications, potentially affecting its efficacy or increasing the risk of side effects. Corticosteroids can reduce the effectiveness of vitamin D by inhibiting its metabolism. Additionally, anticonvulsants such as phenytoin and phenobarbital may accelerate the metabolism of vitamin D, necessitating higher doses to achieve therapeutic levels. Patients taking thiazide diuretics should be monitored closely, as these medications can increase calcium levels and may lead to hypercalcemia when used concurrently with vitamin D supplements.

Precautions

Before starting PURETRIG 5000 IU HP, it is important to consult with a healthcare professional, especially for individuals with pre-existing medical conditions such as kidney disease, hyperparathyroidism, or cardiovascular disorders. Regular monitoring of serum calcium and vitamin D levels is recommended to avoid potential toxicity. Patients should also be advised to maintain a balanced diet rich in calcium and magnesium to support the effects of vitamin D on bone health.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy of vitamin D supplementation in improving bone health and preventing deficiency-related conditions. A systematic review published in the Journal of Clinical Endocrinology & Metabolism highlighted that high-dose vitamin D supplementation significantly increased serum 25-hydroxyvitamin D levels in individuals with deficiency and improved bone mineral density in postmenopausal women. Another study in the American Journal of Clinical Nutrition indicated that vitamin D supplementation reduced the risk of falls in older adults, underscoring its importance in maintaining skeletal health.

Conclusion

PURETRIG 5000 IU HP is a potent vitamin D3 supplement designed to address vitamin D deficiency and support overall bone health. With its well-established mechanism of action and pharmacological properties, this formulation offers a reliable option for individuals at risk of deficiency. However, it is essential to use this product responsibly, adhering to recommended dosages and monitoring for potential side effects. Consultation with a healthcare provider is advised to ensure safe and effective use.